● Recruiting

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Glycopyrronium (Bromide) in Children (6 to Less Than 12 Years) With Asthma

Condition: Asthma · Sponsor: Novartis Pharmaceuticals

PhasePhase 2

Planned participants42

Who can joinAll sexes, 6 Years to 11 Years

Healthy volunteersNo

About this study

The purpose of this study is to characterize the bronchodilator effect, systemic exposure and safety/tolerability of two different doses of inhaled glycopyrronium, when compared to placebo. Outcome of this study will be used to determine the dose of inhaled glycopyrronium for the development of fixed dose combination indacaterol/mometasone/glycopyrronium (QVM149) for children aged 6 to less than 12 years old with moderate to severe asthma.

This description comes directly from the study's public registry record.

Talk to the study team

Novartis Pharmaceuticals · +41613241111 · novartis.email@novartis.com

Novartis Pharmaceuticals

Always discuss trial participation with your own doctor first.

Locations (23)

Novartis Investigative Site	Rousse, Bulgaria	Recruiting
Novartis Investigative Site	Sevlievo, Bulgaria	Recruiting
Novartis Investigative Site	Sofia, Bulgaria	Recruiting
Novartis Investigative Site	Ibague, Tolima Department, Colombia	Recruiting
Novartis Investigative Site	Guatemala City, GTM, Guatemala	Withdrawn
Novartis Investigative Site	Guatemala City, Guatemala	Recruiting
Novartis Investigative Site	Debrecen, Hajdu Bihar Megye, Hungary	Recruiting
Novartis Investigative Site	Budapest, Hungary	Recruiting
Novartis Investigative Site	Budapest, Hungary	Recruiting
Novartis Investigative Site	Eger, Hungary	Recruiting
Novartis Investigative Site	Kaposvár, Hungary	Withdrawn
Novartis Investigative Site	Nagykanizsa, Hungary	Withdrawn

+ 11 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05222529